Skip to content

Assessing How Normal Variations in CT Scanning Affects Its Interpretation

Stability of Radiomic Features for Abdominal Tumors on Contrast Enhanced CT

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT03038568
Enrollment
169
Registered
2017-01-31
Start date
2017-01-27
Completion date
2027-01-27
Last updated
2026-04-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Colorectal Cancer Metastatic

Keywords

colorectal liver metastases, CT scan, 17-010

Brief summary

The purpose of the study is to see how measurements of tumor differences vary with slight changes in CT scan parameters. Reproducible radiomic features can be extracted for abdominal tumors, and specifically colorectal liver metastases, imaged with clinical CT scanners even in the setting of variable scan parameters and variable contrast timing. Participants will be consented to undergo an additional CT of their abdomen.

Interventions

DIAGNOSTIC_TESTCT scan

Patients with colorectal liver metastases scheduled for abdominopelvic CECT will be consented to undergo an additional CT of their abdomen (termed add-on CT) within 15 seconds, before or after, their clinical portal venous phase CT (PV CT), which is performed at a fixed delay of 80 seconds at our institution.

Sponsors

Memorial Sloan Kettering Cancer Center
Lead SponsorOTHER
Queen's University
CollaboratorOTHER

Study design

Observational model
COHORT
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* Patients ≥ 18 years of age on the day of signed informed consent * Patients scheduled and approved for contrast enhanced CT that includes imaging of the abdomen and pelvis following the Department of Radiology standard of care protocol as per local institutional guidelines * Patients with measurable colorectal liver metastases on prior imaging, with at least one tumor greater than 2.0 cm in axial maximal diameter

Exclusion criteria

* Patient who is pregnant and/or lactating * Patient scheduled for CT that includes the abdomen with a multiphasic contrast enhanced protocol (e.g. Triple Phase or Quadruple Phase Liver CT) * Patient who require reduced intravenous contrast dose based on the Department of Radiology contrast policy as per local institutional guidelines * Any other medical condition, including mental illness or substance abuse, deemed by the Investigator to be likely to interfere with a patient's ability to sign informed consent, cooperate and participate in the study, or follow up procedures

Design outcomes

Primary

MeasureTime frameDescription
assess the stability (reproducibility) of radiomic measurements obtained from repeat abdominal CT scans2 yearsThere will be 18 cohorts, each cohort differing by the length of the time gap in acquisition and noise index. In addition each acquisition will be reconstructed in 21 different ways (combinations of 3 slice thicknesses and 7 ASiR levels).

Countries

United States

Contacts

PRINCIPAL_INVESTIGATORKinh Gian Richard Do, MD, PhD

Memorial Sloan Kettering Cancer Center

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Apr 23, 2026